Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP).-临床诊疗知识库

首页 > Annals of oncology : official journal of the Europ... > Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined ...

收藏 | 浏览92

To investigate whether addition of cetuximab to standard adjuvant chemotherapy with gemcitabine improves outcome in pancreatic cancer, specifically whether the rate of disease-free survival (DFS) at 18 months (primary end point) exceeds the previously reported 35

作者：H, Fensterer；C, Schade-Brittinger；H-H, Müller；S, Tebbe；J, Fass；U, Lindig；U, Settmacher；W E, Schmidt；A, M?rten；M P, Ebert；M, Kornmann；R, Hofheinz；E, Endlicher；C, Brendel；P J, Barth；D K, Bartsch；P, Michl；T M, Gress

来源：Annals of oncology : official journal of the European Society for Medical Oncology 2013 年 24卷 10期

循证治疗随机对照研究

相似文献

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求，方便快速、便捷的获取实用的医学信息，辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍

热门关注

免责声明：本知识库提供的有关内容等信息仅供学习参考，不代替医生的诊断和医嘱。